vs
Side-by-side financial comparison of Solana Co (HSDT) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.
Taysha Gene Therapies, Inc. is the larger business by last-quarter revenue ($5.5M vs $5.2M, roughly 1.0× Solana Co). Solana Co runs the higher net margin — 6227.1% vs -507.8%, a 6734.8% gap on every dollar of revenue. On growth, Solana Co posted the faster year-over-year revenue change (2725.9% vs 171.3%). Over the past eight quarters, Solana Co's revenue compounded faster (522.3% CAGR vs 26.8%).
Solana is a Mexican cottage manufacturer of sports, racing, and kids' automobiles based in Mexico City. The family run company has operated since 1936, with a total production of fewer than fifty cars; the majority of them one-offs. The family is heavily involved in motor sports; the most prominent member was Moisés Solana, who raced family-built cars and later in Formula One.
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.
HSDT vs TSHA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.2M | $5.5M |
| Net Profit | $325.6M | $-27.9M |
| Gross Margin | 96.6% | — |
| Operating Margin | -3845.8% | -516.0% |
| Net Margin | 6227.1% | -507.8% |
| Revenue YoY | 2725.9% | 171.3% |
| Net Profit YoY | 8388.0% | -48.3% |
| EPS (diluted) | $111.28 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.2M | $5.5M | ||
| Q3 25 | $697.0K | $0 | ||
| Q2 25 | $43.0K | $2.0M | ||
| Q1 25 | $49.0K | $2.3M | ||
| Q4 24 | $185.0K | $2.0M | ||
| Q3 24 | $51.0K | $1.8M | ||
| Q2 24 | $182.0K | $1.1M | ||
| Q1 24 | $135.0K | $3.4M |
| Q4 25 | $325.6M | $-27.9M | ||
| Q3 25 | $-352.8M | $-32.7M | ||
| Q2 25 | $-9.8M | $-26.9M | ||
| Q1 25 | $-3.8M | $-21.5M | ||
| Q4 24 | — | $-18.8M | ||
| Q3 24 | $-3.7M | $-25.5M | ||
| Q2 24 | $-1.6M | $-20.9M | ||
| Q1 24 | $-2.5M | $-24.1M |
| Q4 25 | 96.6% | — | ||
| Q3 25 | 85.2% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 35.2% | — | ||
| Q1 24 | 8.9% | — |
| Q4 25 | -3845.8% | -516.0% | ||
| Q3 25 | -5086.1% | — | ||
| Q2 25 | -7725.6% | -1347.1% | ||
| Q1 25 | -8185.7% | -930.5% | ||
| Q4 24 | — | -985.8% | ||
| Q3 24 | -7980.4% | -1448.4% | ||
| Q2 24 | -1796.7% | -1915.4% | ||
| Q1 24 | -2530.4% | -713.3% |
| Q4 25 | 6227.1% | -507.8% | ||
| Q3 25 | -50612.3% | — | ||
| Q2 25 | -22867.4% | -1353.6% | ||
| Q1 25 | -7832.7% | -935.2% | ||
| Q4 24 | — | -929.0% | ||
| Q3 24 | -7227.5% | -1427.5% | ||
| Q2 24 | -885.7% | -1882.0% | ||
| Q1 24 | -1863.7% | -705.4% |
| Q4 25 | $111.28 | $-0.08 | ||
| Q3 25 | $-32.89 | $-0.09 | ||
| Q2 25 | $-79.73 | $-0.09 | ||
| Q1 25 | $-0.51 | $-0.08 | ||
| Q4 24 | — | $-0.07 | ||
| Q3 24 | $-744.35 | $-0.10 | ||
| Q2 24 | $-485.30 | $-0.09 | ||
| Q1 24 | $-3.08 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.3M | $319.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $300.9M | $246.9M |
| Total Assets | $303.9M | $343.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.3M | $319.8M | ||
| Q3 25 | $124.1M | $297.3M | ||
| Q2 25 | $6.1M | $312.8M | ||
| Q1 25 | $1.1M | $116.6M | ||
| Q4 24 | $1.1M | $139.0M | ||
| Q3 24 | $3.5M | $157.7M | ||
| Q2 24 | $6.4M | $172.7M | ||
| Q1 24 | $3.6M | $124.0M |
| Q4 25 | $300.9M | $246.9M | ||
| Q3 25 | $-152.4M | $219.0M | ||
| Q2 25 | $6.0M | $248.7M | ||
| Q1 25 | $1.3M | $55.1M | ||
| Q4 24 | $1.1M | $71.5M | ||
| Q3 24 | $3.8M | $88.8M | ||
| Q2 24 | $6.3M | $108.9M | ||
| Q1 24 | $2.0M | $53.8M |
| Q4 25 | $303.9M | $343.3M | ||
| Q3 25 | $475.9M | $316.6M | ||
| Q2 25 | $7.9M | $333.3M | ||
| Q1 25 | $3.5M | $138.4M | ||
| Q4 24 | $3.5M | $160.4M | ||
| Q3 24 | $5.6M | $180.2M | ||
| Q2 24 | $8.8M | $200.4M | ||
| Q1 24 | $5.8M | $153.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.5M | $-26.7M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.05× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.5M | $-26.7M | ||
| Q3 25 | $-4.0M | $-24.2M | ||
| Q2 25 | $-2.8M | $-20.2M | ||
| Q1 25 | $-3.5M | $-22.0M | ||
| Q4 24 | $-11.0M | $-18.3M | ||
| Q3 24 | $-2.8M | $-21.6M | ||
| Q2 24 | $-2.9M | $-21.5M | ||
| Q1 24 | $-3.0M | $-19.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-24.3M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-11.0M | $-18.3M | ||
| Q3 24 | — | $-21.6M | ||
| Q2 24 | — | $-21.7M | ||
| Q1 24 | $-3.0M | $-19.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -5970.8% | -905.5% | ||
| Q3 24 | — | -1210.9% | ||
| Q2 24 | — | -1951.9% | ||
| Q1 24 | -2226.7% | -584.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.7% | 0.1% | ||
| Q3 24 | 0.0% | 2.0% | ||
| Q2 24 | 0.0% | 18.1% | ||
| Q1 24 | 3.7% | 4.1% |
| Q4 25 | -0.05× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
